Study Projects Dramatic Increase in ALS Prevalence by 2040
A new study projects that global ALS prevalence will rise by about 25% by 2040—driven largely by an aging population and improved survival.
A new study projects that global ALS prevalence will rise by about 25% by 2040—driven largely by an aging population and improved survival.
Scientists at UT Southwestern have identified the protein GADD45G as a master regulator of reactive gliosis, a damaging process in neurodegenerative diseases like Parkinson's and Alzheimer’s, offering a potential new therapeutic target.
Innovations in rehabilitation techniques—from telehealth to advanced neurotechnology—are enhancing recovery outcomes for stroke survivors.
LimFlow’s FDA approval follows study results which found that the therapy enabled most patients treated to keep their leg and experience wound healing.
As more adults focus on improving their health in 2025, this is a good time to stress the importance of patients maintaining fine motor skills through targeted exercises and recreational activities to preserve independence and quality of life.
For the study, researchers looked at 546 people ages 18 to 49 who had an unexplained stroke and asked about their habits, including smoking.
A four-year distribution agreement for the Provizio SEM Scanner, used to prevent pressure injuries, has not been extended.
Identifying critical proteins like LRP1 could be a key step toward novel therapeutic approaches for skeletal conditions such as developmental dysplasia of the hip and osteoarthritis.
Scientists developed an immunotherapy to minimize the damage from traumatic spinal cord injury, instead of repairing damaged tissue.